Last reviewed · How we verify
NCT07176325
Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation
trial testing Creatine Monohydrate in Side Effects of Creatine Monohydrate Dosing in 24 participants. Completed in 3 July 2024.
3 July 2024
Quick facts
| Lead sponsor | Vireo Systems, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 30 May 2024 |
| Primary completion | 3 July 2024 |
| Estimated completion | 3 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Creatine Monohydrate — full drug profile →
Conditions studied
- Side Effects of Creatine Monohydrate Dosing — all drugs for Side Effects of Creatine Monohydrate Dosing →
Sponsor
Vireo Systems, Inc.
Who can join
Adults 18 to 60, any sex, with Side Effects of Creatine Monohydrate Dosing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07176325
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Creatine Monohydrate
Trials testing the same drug.
- NCT07275996 — Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Functio · NA · not yet recruiting
- NCT07475676 — Effects of Short-term Acute Creatine Supplementation on Power, Speed and Muscular Strengths in Young Football Players · NA · not yet recruiting
- NCT07534293 — Effects of 7-Day Creatine Supplementation on Cognitive Function After High-Intensity Interval Training in Active Young M · NA · completed
- NCT07225335 — Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females · NA · completed
- NCT07451496 — PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) · NA · recruiting
Other Vireo Systems, Inc. trials
Trials by the same sponsor.
- NCT06977854 — The Objective of This Study Was to Compare and Quantify the Bioavailability of Citrulline Byproducts in Blood Samples an · completed
- NCT07521059 — Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07176325 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vireo Systems, Inc.
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07176325.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing